Pharma Journalist - Page 764 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Shire submits lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe

Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development

Regeneron to discontinue development of Suptavumab for respiratory syncytial virus

Adents obtains gateway provider certification from EMVO

Array BioPharma Appoints Curtis Oltmans As General Counsel

Oxford BioMedica announces a £2 million two-year collaboration co-funded by Innovate UK

Takeda Announces Alliance with Stanford University to Drive Therapeutic Discoveries

PharmaMar Starts a Quadruple Combination Study With Aplidin for the Treatment of Multiple Myeloma

Soin Neuroscience Signs Drug Development Deal for Non Addicting Pain Killer

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy